Welcure Drugs Boosts Market Liquidity with Stock Split and Bonus Issue

Welcure Drugs & Pharmaceuticals announces board-approved initiatives to increase market liquidity with a stock split and bonus share issue. Additionally, the firm plans to raise up to Rs 80 crore through a qualified institutional placement to fund ambitious expansion plans, including setting up an agro-pharma research laboratory.

In a strategic move to enhance market liquidity and widen shareholding, Welcure Drugs & Pharmaceuticals announced board approval for a stock split and bonus share issue. The company will execute a 10:1 stock split and issue bonus shares on a 1:10 ratio.

Alongside these measures, Welcure plans to raise up to Rs 80 crore via a qualified institutional placement (QIP) to fund its expansion strategies. The decision comes in light of Welcure's impressive Q1FY26 financial outcomes.

The company is setting its sights on further growth with a proposal to establish an agro-pharma research laboratory, enhancing its research capabilities and market presence.

(With inputs from agencies.)